3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gynecologic
2
Gastrointestinal
2
Other neoplasm
1
Other
1
Genitourinary
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
fludarabine
2
Specimen Handling
2
Patient Reported Outcome Measures
2
Methods
2
Mesna
2
Educational Status
2
Early Intervention, Educational
2
radium Ra 223 dichloride
1
abemaciclib
1
X-Rays
1
Taxes
1
Surveys and Questionnaires
1
Sirolimus
1
Robotic Surgical Procedures
1
Resistance Training
1
Radiotherapy
1
Photons
1
Paclitaxel
1
Nivolumab
1
Morphine
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Robotic Surgical Procedures
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled